Open
公司以3D病理影像技術支援精準醫療診斷，已開發出全球首創搭載AI模組的3D病理影像分析軟體Metalite，輔助判斷臨床檢體組織，形態變異及腫瘤標靶分子分佈情形，提高癌症診斷及新藥開發成功率。
目前合作的對象有：Intel、Boehringer-Ingelheim、Astra Zeneca。
JelloX Biotech Inc. is a next generation pathology company that revolutionizes the way to image tissue biopsy with an extra dimension. JelloX 3D imaging technology not only scans clinical tissue samples as a whole, but also preserves tissue structural integrity to cellular level, thus providing hundreds times more data and comprehensive profile of valuable biopsy. Key features of our proprietary technology include high accuracy, convenience, and efficiency with quantitative characterization of clinical tissue biopsy such as cell counts, density, distance, biomarker expression percentage and distribution profile, as well as tumor microenvironment. Along with our AI Algorithm and 3D pathology database, we are building an auxiliary diagnostic system to assist patient screening in clinical trials; our ultimate goal is to enhance probability-of-success of new cancer drug development for global biotech companies and pharmaceutical companies.
JelloX Service Model
Flexible quotation package upon request
• Standard sample size: 1 cm x 1 cm x 0.2 mm
• Scanning interval: 1 μm (>100 x information than conventional 2D slide)
• Formalin fixed or FFPE archive tissue block
• Nuclear + membrane + 1 biomarker staining: NT$ 40k/sample
• Nuclear + membrane + 2 biomarker staining: NT$ 50k/sample
• Software as viewer with basic analysis: Free
• Customer made AI analysis: Special quotation package
• Bulk order > 10 samples each: Special quotation package
• R&D Proof-of-concept project for feasibility study: Special quotation package • PI/Biotech/Pharma-initiated clinical study: Special quotation package
目前合作的對象有：Intel、Boehringer-Ingelheim、Astra Zeneca。
JelloX Biotech Inc. is a next generation pathology company that revolutionizes the way to image tissue biopsy with an extra dimension. JelloX 3D imaging technology not only scans clinical tissue samples as a whole, but also preserves tissue structural integrity to cellular level, thus providing hundreds times more data and comprehensive profile of valuable biopsy. Key features of our proprietary technology include high accuracy, convenience, and efficiency with quantitative characterization of clinical tissue biopsy such as cell counts, density, distance, biomarker expression percentage and distribution profile, as well as tumor microenvironment. Along with our AI Algorithm and 3D pathology database, we are building an auxiliary diagnostic system to assist patient screening in clinical trials; our ultimate goal is to enhance probability-of-success of new cancer drug development for global biotech companies and pharmaceutical companies.
JelloX Service Model
Flexible quotation package upon request
• Standard sample size: 1 cm x 1 cm x 0.2 mm
• Scanning interval: 1 μm (>100 x information than conventional 2D slide)
• Formalin fixed or FFPE archive tissue block
• Nuclear + membrane + 1 biomarker staining: NT$ 40k/sample
• Nuclear + membrane + 2 biomarker staining: NT$ 50k/sample
• Software as viewer with basic analysis: Free
• Customer made AI analysis: Special quotation package
• Bulk order > 10 samples each: Special quotation package
• R&D Proof-of-concept project for feasibility study: Special quotation package • PI/Biotech/Pharma-initiated clinical study: Special quotation package